Last Updated : November 5, 2021
CADTH seeks patients’ perspectives to improve the relevance and quality of our reviews. Also, to enable those possibly affected by the reviews to have an opportunity to contribute to them. For reimbursement reviews and provisional funding algorithms, CADTH invites patient groups to contribute relevant input and feedback.
To seek public reimbursement for a drug, a pharmaceutical company applies to CADTH. CADTH issues an open call for patient input. CADTH sends out notifications for these open calls every Thursday, through its CADTH Weekly Update. Calls for patient input are also highlighted on the open calls page of the CADTH website.
Following CADTH’s review and expert committee deliberations, draft reimbursement recommendations are shared for feedback. New draft recommendations and open calls for feedback are highlighted in the CADTH Weekly Update.
CADTH issues a call for stakeholder input for all provisional funding algorithm projects. Open calls for input are highlighted in the CADTH Weekly Update.
To provide initial input at the outset of the provisional funding algorithm project:
CADTH issues a call for stakeholder feedback on all draft provisional funding algorithms. Open calls for feedback are highlighted in the CADTH Weekly Update.
To provide stakeholder feedback on a draft provisional funding algorithm:
If you have questions or need help to participate, please contact PatientEngagement@cadth.ca or call CADTH at 1 866 988 1444.
To learn more about CADTH reimbursement review process, you can to the Procedures for CADTH Reimbursement Reviews.